Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBOP/BEP vs BEP in Poor Prognosis Germ Cell Tumors
NCT00301782Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Jun 2005
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine, carboplatin in germ cell tumor (GCT), sponsored by Medical Research Council. Started Jun 2005; status: completed.
02
Drugs
vincristinecarboplatin
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00301782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301782.